Is  	Is  	 VBZ	O
pentoxifylline  	pentoxifylline  	 JJ	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
alcoholic  	alcoholic  	 JJ	O
hepatitis 	hepatitis 	 NN	O
?  	?  	 VBZ	O
First  	First  	 RB	O
update  	update  	 VB	O
This  	This  	 DT	O
article  	article  	 NN	O
updates  	updates  	 NNS	O
the  	the  	 DT	O
June  	June  	 NNP	O
2014  	2014  	 CD	O
Living  	Living  	 NNP	B-NP
FRISBEE  	FRISBEE  	 NNP	I-NP
( 	( 	 -LRB-	O
Living  	Living  	 NNP	B-NP
FRISBEE 	FRISBEE 	 NNP	I-NP
:  	:  	 :	I-NP
Living  	Living  	 NNP	I-NP
FRIendly  	FRIendly  	 NNP	I-NP
Summary  	Summary  	 NNP	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
Body  	Body  	 NN	I-NP
of  	of  	 IN	I-NP
Evidence  	Evidence  	 NN	I-NP
using  	using  	 VBG	O
Epistemonikos 	Epistemonikos 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
It  	It  	 PRP	O
incorporates  	incorporates  	 VBZ	O
a  	a  	 DT	O
new  	new  	 JJ	O
systematic  	systematic  	 JJ	B-NP
review  	review  	 NN	I-NP
identifying  	identifying  	 VBG	O
one  	one  	 CD	O
study  	study  	 NN	O
not  	not  	 RB	O
included  	included  	 VBN	O
in  	in  	 IN	O
previous  	previous  	 JJ	O
reviews 	reviews 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
new  	new  	 JJ	O
evidence  	evidence  	 NN	O
leads  	leads  	 VBZ	O
to  	to  	 TO	O
substantial  	substantial  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
existing  	existing  	 JJ	O
evidence 	evidence 	 NN	O
.  	.  	 .	O
Pentoxifylline  	Pentoxifylline  	 NNP	B-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
inhibitor  	inhibitor  	 NN	O
of  	of  	 IN	O
tumor  	tumor  	 NN	B-NP
necrosis  	necrosis  	 NN	I-NP
factor 	factor 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
proposed  	proposed  	 VBN	O
as  	as  	 IN	O
treatment  	treatment  	 NN	O
for  	for  	 IN	O
alcoholic  	alcoholic  	 JJ	O
hepatitis 	hepatitis 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
not  	not  	 RB	O
clear  	clear  	 JJ	O
if  	if  	 IN	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
effective 	effective 	 JJ	O
,  	,  	 ,	O
or  	or  	 CC	O
if  	if  	 IN	O
it  	it  	 PRP	O
adds  	adds  	 VBZ	O
benefit  	benefit  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
corticosteroids 	corticosteroids 	 NN	B-NP
.  	.  	 .	O
Searching  	Searching  	 VBG	O
in  	in  	 IN	O
Epistemonikos  	Epistemonikos  	 NNP	B-NP
database 	database 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
maintained  	maintained  	 VBN	O
by  	by  	 IN	O
screening  	screening  	 VBG	O
30  	30  	 CD	O
databases 	databases 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
identified  	identified  	 VBD	O
three  	three  	 CD	O
systematic  	systematic  	 JJ	B-NP
reviews  	reviews  	 NNS	I-NP
including  	including  	 VBG	O
eight  	eight  	 CD	O
randomized  	randomized  	 NNS	O
controlled  	controlled  	 VBN	B-NP
trials  	trials  	 NNS	I-NP
addressing  	addressing  	 VBG	O
the  	the  	 DT	O
question  	question  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
article 	article 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
combined  	combined  	 VBD	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
using  	using  	 VBG	O
meta-analysis  	meta-analysis  	 JJ	B-NP
and  	and  	 CC	O
generated  	generated  	 VBD	O
a  	a  	 DT	O
summary  	summary  	 NN	O
of  	of  	 IN	O
findings  	findings  	 NNS	O
following  	following  	 VBG	O
the  	the  	 DT	O
GRADE  	GRADE  	 NNP	B-NP
approach 	approach 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
concluded  	concluded  	 VBD	O
pentoxifylline  	pentoxifylline  	 VBN	O
probably  	probably  	 RB	O
leads  	leads  	 VBZ	O
to  	to  	 TO	O
little  	little  	 JJ	O
or  	or  	 CC	O
no  	no  	 DT	O
difference  	difference  	 NN	O
in  	in  	 IN	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
alcoholic  	alcoholic  	 JJ	O
hepatitis 	hepatitis 	 NN	O
.  	.  	 .	O
Abstract  	Abstract  	 JJ	B-NP
available  	available  	 JJ	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
publisher 	publisher 	 NN	O
. 	. 	 .	O
